Displaying 1 to 20 of 33 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development |
United States | N/A Active |
||
|
|
Adlyfe |
United States | 1 Jan 2006 | Series A Active |
|
|
|
Aerovance Inc |
United States | 1 Apr 2009 | N/A Active |
|
|
|
Aerovance Inc |
United States | 1 Mar 2007 | Series C Initial investment. Round participant. Active |
|
|
AgraQuest Inc Discovery, development, manufacturing and marketing of biopesticides and low-chem pest and disease control, and yield enhancing products. |
United States | N/A Active |
||
|
|
Akermin Inc |
United States | N/A Active |
||
|
|
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | 1 Nov 2008 | Series A |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Feb 2006 | Series B |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Dec 2008 | Series C |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Oct 2004 | Series A |
|
|
|
Cellomics Inc |
United States | N/A |
||
|
|
Ceptaris Therapeutics Inc Specialty pharmaceuticals company. |
United States | 1 Jun 2012 | Series D Active |
|
|
diaDexus Inc Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value |
United States | 1 Jan 2007 | Series E Active |
|
|
|
elbion AG |
Germany | N/A Active |
||
|
|
Endocyte Inc Folate-based cancer and autoimmune disease therapies |
United States | 1 Jan 2010 | Series C |
|
|
|
FerroKin Biosciences Inc A clinical stage biotechnology company dedicated to improving the management of patients with iron overload. |
United States | N/A |
||
|
|
Immunicon Corp Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. |
United States | N/A |
||
|
|
Inhibitex Inc |
United States | N/A |
||
|
|
Intranasal Therapeutics Inc Specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products. |
United States | N/A |
||
|
|
Light Sciences Oncology Inc Drug-device cancer therapy |
United States | 1 Jul 2007 | Series B |